This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Apple brings back blood oxygen meters in setback for Masimo

By Nick Robertson ( August 15, 2025, 20:44 GMT | Insight) -- Apple’s decision to reimplement the blood oxygen feature in its Apple Watch devices following a ruling by US Customs and Border Patrol — avoiding an exclusion order by the US International Trade Commission — is a significant setback for Masimo as it argues in favor of the order in court.Following oral arguments at the US Court of Appeals for the Federal Circuit last month where Masimo appeared to be on track to win its case against Apple, Apple’s reintroduction of the blood oxygen feature to its Apple Watch products Thursday halts Masimo’s legal momentum. The move, which Apple said follows a recent ruling by US Customs and Border Patrol, hurts Masimo’s potential for a hefty settlement....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login